TP53 and cancer: Variant data suggested that 4 of the cancer organoids and respective parental tumor tissue, exhibited mutations in common RCC drivers, RCC pathological‐related genes and cancer drivers, such as VHL, PBRM1, KMT2C, BAP1, PIK3CA and TP53 (Figure 6).